{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:21Z","timestamp":1791407001011,"version":"4.3.3"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["2022\\u20132024"],"award-info":[{"award-number":["2022\\u20132024"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["JYLJ202014"],"award-info":[{"award-number":["JYLJ202014"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijcard.2025.133529","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:23:14Z","timestamp":1751422994000},"page":"133529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Systemic immune-inflammation index as a predictor of statin residual cardiovascular risk compared with C-reactive protein"],"prefix":"10.1016","volume":"438","author":[{"given":"Yihua","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ijcard.2025.133529_bb0005","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.ijcard.2025.133529_bb0010","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980-2000","volume":"356","author":"Ford","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ijcard.2025.133529_bb0015","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10204","key":"10.1016\/j.ijcard.2025.133529_bb0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcard.2025.133529_bb0025","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.133529_bb0030","series-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","year":"2025"},{"issue":"9753","key":"10.1016\/j.ijcard.2025.133529_bb0035","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"9493","key":"10.1016\/j.ijcard.2025.133529_bb0040","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ijcard.2025.133529_bb0045","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/cvr\/cvab032","article-title":"Emerging views of statin pleiotropy and cholesterol lowering","volume":"118","author":"Yu","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"14","key":"10.1016\/j.ijcard.2025.133529_bb0055","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.ijcard.2025.133529_bb0060","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.ijcard.2025.133529_bb0065","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.3390\/jcm12185989","article-title":"Management of residual risk in chronic coronary syndromes. Clinical pathways for a quality-based secondary prevention","volume":"12","author":"Giubilato","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2025.133529_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fcvm.2020.00088","article-title":"The evolving understanding and approach to residual cardiovascular risk management","volume":"7","author":"Dhindsa","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133529_bb0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12944-024-02156-3","article-title":"The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention","volume":"23","author":"Liao","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"46","key":"10.1016\/j.ijcard.2025.133529_bb0080","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.ijcard.2025.133529_bb0085","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.jacc.2019.01.077","article-title":"Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention","volume":"73","author":"Guedeney","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2025.133529_bb0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11883-020-00883-3","article-title":"Targeting inflammation to reduce residual cardiovascular risk","volume":"22","author":"Ajala","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133529_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133529_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000286","article-title":"Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease","volume":"7","author":"Hemingway","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijcard.2025.133529_bb0105","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9343475","article-title":"Both low and high postprocedural hsCRP associate with increased risk of death in acute coronary syndrome patients treated by percutaneous coronary intervention","volume":"2020","author":"Chen","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijcard.2025.133529_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/JIR.S283835","article-title":"The associations of two novel inflammation indexes, SII and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85,154 individuals","volume":"14","author":"Jin","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"17","key":"10.1016\/j.ijcard.2025.133529_bb0115","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.3390\/ijms23179553","article-title":"Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijcard.2025.133529_bb0120","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MCA.0000000000001037","article-title":"Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease","volume":"32","author":"Liu","year":"2021","journal-title":"Coron. Artery Dis."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/pace.14436","article-title":"Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction","volume":"45","author":"Hay\u0131ro\u011flu","year":"2022","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133529_bb0130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/jcm12031128","article-title":"Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults","volume":"12","author":"Xia","year":"2023","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2025.133529_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13230","article-title":"Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease","volume":"50","author":"Yang","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"issue":"23","key":"10.1016\/j.ijcard.2025.133529_bb0140","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijcard.2025.133529_bb0145","series-title":"The Linkage of National Center for Health Statistics Survey Data to the National Death Index\u20142015 Linked Mortality File (LMF): Methodology Overview and Analytic Considerations","year":"2019"},{"key":"10.1016\/j.ijcard.2025.133529_bb0150","series-title":"International Statistical Classification of Diseases and Related Health Problems, 10th Revision","year":"2016"},{"issue":"162","key":"10.1016\/j.ijcard.2025.133529_bb0155","first-page":"1","article-title":"National health and nutrition examination survey: sample design, 2011\u20132014","volume":"2","author":"Johnson","year":"2014","journal-title":"Vital Health Stat."},{"issue":"10384","key":"10.1016\/j.ijcard.2025.133529_bb0160","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ijcard.2025.133529_bb0165","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2025.133529_bb0170","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3390\/ijms23073418","article-title":"Molecular biological and clinical understanding of the statin residual cardiovascular disease risk and peroxisome proliferator-activated receptor alpha agonists and ezetimibe for its treatment","volume":"23","author":"Yanai","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.ijcard.2025.133529_bb0175","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur. Heart J."},{"issue":"17\u201318","key":"10.1016\/j.ijcard.2025.133529_bb0180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/17520363.2024.2395236","article-title":"Comparison of inflammatory markers for the prediction of atrial fibrillation recurrence following cryoablation","volume":"18","author":"Kalenderoglu","year":"2024","journal-title":"Biomark. Med"},{"issue":"20","key":"10.1016\/j.ijcard.2025.133529_bb0185","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.3390\/jcm13206059","article-title":"Advanced lung cancer inflammation index as predictor of all-cause mortality in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention","volume":"13","author":"Trimarchi","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2025.133529_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133165","article-title":"Comparison of the clinical value of inflammatory blood biomarkers in relation to disease severity and survival in chronic heart failure","volume":"429","author":"Szymczak","year":"2025","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133529_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.933913","article-title":"Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis","volume":"9","author":"Ye","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0200","article-title":"The relationship between the systemic immune-inflammation index and ischemia with non-obstructive coronary arteries in patients undergoing coronary angiography","volume":"121","author":"Karakayali","year":"2024","journal-title":"Arq. Bras. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133529_bb0205","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/clc.23829","article-title":"The association between systemic inflammatory response index and in-hospital mortality in patients with infective endocarditis","volume":"45","author":"Cai","year":"2022","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133529_bb0210","article-title":"Association of systemic immune inflammatory index with all-cause and cause-specific mortality in hypertensive individuals: results from NHANES","volume":"14","author":"Cao","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133529_bb0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41569-019-0326-7","article-title":"Neutrophils as regulators of cardiovascular inflammation","volume":"17","author":"Silvestre-Roig","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"17","key":"10.1016\/j.ijcard.2025.133529_bb0220","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1016\/j.cell.2021.07.004","article-title":"Selective activation of PFKL suppresses the phagocytic oxidative burst","volume":"184","author":"Amara","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ijcard.2025.133529_bb0225","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.immuni.2021.05.007","article-title":"GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ijcard.2025.133529_bb0230","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajpath.2024.05.010","article-title":"Platelets in thrombosis and atherosclerosis: a double-edged sword","volume":"194","author":"Martinez Bravo","year":"2024","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133529_bb0235","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/cells11061014","article-title":"Platelets, a key cell in inflammation and atherosclerosis progression","volume":"11","author":"Huilcaman","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3899\/jrheum.211411","article-title":"Red cell distribution width and absolute lymphocyte count associate with biomarkers of inflammation and subsequent mortality in rheumatoid arthritis","volume":"50","author":"Lange","year":"2023","journal-title":"J. Rheumatol."},{"issue":"21","key":"10.1016\/j.ijcard.2025.133529_bb0245","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.2174\/092986711796391633","article-title":"Low lymphocyte count and cardiovascular diseases","volume":"18","author":"N\u00fa\u00f1ez","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133529_bb0250","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/ijms24032079","article-title":"Monomeric C-reactive protein in atherosclerotic cardiovascular disease: advances and perspectives","volume":"24","author":"Melnikov","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ijcard.2025.133529_bb0255","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/eurheartj\/ehac055","article-title":"Targeted proteomics improves cardiovascular risk prediction in secondary prevention","volume":"43","author":"Nurmohamed","year":"2022","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2025.133529_bb0260","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamacardio.2022.4277","article-title":"Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the RESCUE clinical trial","volume":"8","author":"Adamstein","year":"2023","journal-title":"JAMA Cardiol."},{"issue":"20","key":"10.1016\/j.ijcard.2025.133529_bb0270","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the inflammasome in chronic coronary artery disease: a LoDoCo2 proteomic substudy","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0275","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2337\/db21-0490","article-title":"Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia","volume":"71","author":"Yousri","year":"2022","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ijcard.2025.133529_bb0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00281-017-0666-5","article-title":"Hemostasis, endothelial stress, inflammation, and the metabolic syndrome","volume":"40","author":"Grandl","year":"2018","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ijcard.2025.133529_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110691","article-title":"Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions","volume":"200","author":"Suren Garg","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133529_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Invest."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325005728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325005728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:51:32Z","timestamp":1776919892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325005728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"alternative-id":["S0167527325005728"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133529","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic immune-inflammation index as a predictor of statin residual cardiovascular risk compared with C-reactive protein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"133529"}}